| Myeloid-derived suppressor cells—new and exciting players in lung cancer Z Yang, J Guo, L Weng, W Tang, S Jin, W Ma Journal of hematology & oncology 13 (1), 10, 2020 | 155 | 2020 |
| MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma Z Yao, T Yuan, H Wang, S Yao, Y Zhao, Y Liu, S Jin, J Chu, Y Xu, W Zhou, ... Tumor Biology 39 (6), 1010428317700411, 2017 | 62 | 2017 |
| Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA K Cui, S Jin, Y Du, J Yu, H Feng, Q Fan, W Ma Cancer Cell International 19, 1-10, 2019 | 43 | 2019 |
| Detection and clinical significance of circulating tumor cells in colorectal cancer M Jiang, S Jin, J Han, T Li, J Shi, Q Zhong, W Li, W Tang, Q Huang, ... Biomarker research 9, 1-20, 2021 | 40 | 2021 |
| Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment S Jin, Z Yang, X Hao, W Tang, W Ma, H Zong Biomarker Research 8 (1), 21, 2020 | 37 | 2020 |
| Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1 S Jin, H Su, NT Tran, J Song, SS Lu, Y Li, S Huang, O Abdel-Wahab, ... PloS one 12 (5), e0175523, 2017 | 35 | 2017 |
| Nanoscale dual-enzyme cascade metal–organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy S Jin, L Weng, Z Li, Z Yang, L Zhu, J Shi, W Tang, W Ma, H Zong, W Jiang Journal of Materials Chemistry B 8 (21), 4620-4626, 2020 | 34 | 2020 |
| PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells S Jin, Y Mi, J Song, P Zhang, Y Liu Experimental and therapeutic medicine 15 (3), 2563-2568, 2018 | 20 | 2018 |
| Methylation of dual-specificity phosphatase 4 controls cell differentiation H Su, M Jiang, C Senevirathne, S Aluri, T Zhang, H Guo, J Xavier-Ferrucio, ... Cell reports 36 (4), 2021 | 16 | 2021 |
| Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II … S Jin, R Zhao, C Zhou, Q Zhong, J Shi, C Su, Q Li, X Su, H Chi, X Lu, ... International Journal of Cancer 152 (8), 1648-1658, 2023 | 15 | 2023 |
| LncRNA BC200 promotes esophageal squamous cell cancer migration and invasion and can regulate ATF4 expression R Zhao, X Cao, S Jin, R Li, Q Zhong, M Jiang, J Han, C Guo, H Zong Frontiers in Oncology 10, 1392, 2020 | 14 | 2020 |
| Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options S Yao, J Li, Z Yao, Y Xu, J Chu, J Zhang, S Jin, Y Huang, J Zhang, J Ma, ... Chinese Journal of Cancer Research 29 (1), 57, 2017 | 14 | 2017 |
| Phase II study of anlotinib plus sintlimab as second-line treatment for patients with advanced biliary tract cancers. H Zong, Q Zhong, R Zhao, S Jin, C Zhou, X Zhang, J Shi, S Qiao, J Han, ... Journal of Clinical Oncology 39 (3_suppl), 307-307, 2021 | 11 | 2021 |
| Sensitive and specific detection of circulating tumor cells promotes precision medicine for cancer QQ Huang, XX Chen, W Jiang, SL Jin, XY Wang, W Liu, SS Guo, JC Guo, ... J Cancer Metastasis Treat 5, 34, 2019 | 10 | 2019 |
| Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production Z Yang, J Guo, K Cui, Y Du, H Zhao, L Zhu, L Weng, W Tang, J Guo, ... Biomedicine & Pharmacotherapy 131, 110740, 2020 | 8 | 2020 |
| Accurate and portable tumor exosomes detection based on manganese dioxide and aptamer-functionalized fluorescent microspheres mediated dual-mode lateral flow assay J Chen, J Guo, M Hu, Y Wang, F Hua, HM Meng, S Jin Sensors and Actuators B: Chemical 409, 135614, 2024 | 6 | 2024 |
| Distinct clinical pattern of colorectal cancer patients with POLE mutations: a retrospective study on real-world data M Jiang, Y Jia, J Han, J Shi, C Su, R Zhang, M Xing, S Jin, H Zong Frontiers in Genetics 13, 963964, 2022 | 6 | 2022 |
| A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell … H Wang, Z Yao, H Tang, Y Zhao, S Jin, W Zhou, S Yao, S Yang, Y Liu, ... Oncotarget 8 (5), 7540, 2017 | 6 | 2017 |
| Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy B Zhang, J Shi, X Shi, X Xu, L Gao, S Li, M Liu, M Gao, S Jin, J Zhou, ... Drug Resistance Updates 74, 101068, 2024 | 5 | 2024 |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs Q Zhao, H Zong, P Zhu, C Su, W Tang, Z Chen, S Jin Experimental Hematology & Oncology 13 (1), 6, 2024 | 5 | 2024 |
